BASF Report 2021 Consoli dated Financial Statements – Notes 216 Segments 2021 Million € Industrial Surface Nutrition & Agricultural Chemicals Materials Solutions Technologies Care Solutions Other BASF Group Sales 13,579 15,214 8,876 22,659 6,442 8,162 3,666 78,598 Intersegment transfers 4,269 1,250 420 171 491 40 120 6,761 Sales including transfers 17,848 16,464 9,296 22,831 6,933 8,202 3,786 85,358 Income from integral companies accounted for using the equity method 409 20 9 94 6 − 136 675 Income from operations (EBIT) 2,997 2,345 965 761 554 696 −641 7,677 Assets 10,369 11,286 6,302 13,769 7,231 15,305 23,121 87,383 of which goodwill 199 189 631 2,373 874 3,187 66 7,520 other intangible assets 55 632 172 1,104 379 3,596 41 5,980 property, plant and equipment 4,734 4,732 2,025 3,817 2,716 2,570 959 21,553 integral investments accounted for using the equity method 1,199 212 21 484 42 − 582 2,540 Liabilities 3,820 4,372 2,621 3,678 3,146 4,091 23,573 45,301 Research and development expenses 97 193 175 296 172 904 378 2,216 Additions to property, plant and equipment and intangible assets (including acquisitions) 1,157 709 361 1,469 654 347 183 4,881 Depreciation and amortization of property, plant and equipment and intangible assets 767 817 380 483 413 662 157 3,678 of which impairments and reversals of impairmentsa 31 33 43 9 6 8 14 144 a Impairments and reversals of impairments included reversals of impairments of €12 million in Industrial Solutions in 2021.